REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330AB5. A total of 22 filers reported holding REVANCE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,418 | -47.2% | 110,000 | -30.8% | 0.00% | -40.0% |
| Q2 2023 | $167,586 | -14.1% | 159,000 | 0.0% | 0.01% | -28.6% |
| Q1 2023 | $195,014 | +108846.4% | 159,000 | -18.9% | 0.01% | +16.7% |
| Q4 2022 | $179 | -99.9% | 196,000 | 0.0% | 0.01% | -25.0% |
| Q3 2022 | $213,000 | +113.0% | 196,000 | +125.3% | 0.01% | +100.0% |
| Q3 2021 | $100,000 | -1.0% | 87,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $101,000 | – | 87,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antara Capital LP | 49,500,000 | $47,535,000 | 1.45% |
| ZAZOVE ASSOCIATES LLC | 16,238,000 | $15,254,000 | 1.34% |
| Kohlberg Kravis Roberts & Co. L.P. | 26,000,000 | $24,456,000 | 0.22% |
| WEDBUSH SECURITIES INC | 30,000 | $2,807,000 | 0.13% |
| AVIVA PLC | 15,000,000 | $14,034,000 | 0.07% |
| Context Capital Management, LLC | 1,000 | $951,000 | 0.06% |
| LMR Partners LLP | 4,500,000 | $4,242,000 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,500,000 | $14,580,000 | 0.04% |
| LAZARD ASSET MANAGEMENT LLC | 27,770,000 | $26,121,000 | 0.03% |
| FRANKLIN RESOURCES INC | 48,000,000 | $45,150,000 | 0.02% |